ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,678, issued on July 15, was assigned to Stemline Therapeutics Inc. (New York).
"Cancer stem cell targeted cancer vaccines" was invented by Ivan Bergstein (New York), Christopher Brooks (Brooklyn, N.Y.) and Thomas P. Cirrito (Long Island City, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are cancer stem cell targeted cancer vaccines and methods for treating and vaccinating against cancer. Also contained herein are regimens by which cancer stem cell targeted cancer vaccines are administered, such regimens comprising peptides, compositions, immunomodulatory agents, and emulsifiers. Also provided are the patient populations to whi...